12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Celldex completes follow-on

Celldex Therapeutics Inc. (NASDAQ:CLDX), Needham, Mass.
Business: Cancer, Infectious, Renal
Date completed: 12/4/13
Type:...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >